Literature DB >> 20379284

Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy.

Andrea K Leung, Daniel J Weisbrod, Carol Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20379284     DOI： 10.3129/i09-253

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  4 in total

1.  Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature.

Authors:  Dimitrios Brouzas; Antonios Charakidas; Tryfon Rotsos; Marilita M Moschos; Helen Loukianou; Chryssanthy Koutsandrea; Ioannis Ladas; Stefanos Baltatzis
Journal:  Clin Ophthalmol       Date:  2010-08-09

Review 2.  Punctate inner choroidopathy: a systematic review.

Authors:  Joana Campos; António Campos; Sílvia Mendes; Arminda Neves; Diana Beselga; Jp Castro Sousa
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

3.  Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  Yuting Peng; Xiongze Zhang; Lan Mi; Bing Liu; Chengguo Zuo; Miaoling Li; Feng Wen
Journal:  BMC Ophthalmol       Date:  2017-06-12       Impact factor: 2.209

4.  Punctate inner choroidopathy: a clinical case report.

Authors:  Joana Campos; António Campos; Diana Beselga; Sílvia Mendes; Arminda Neves; J P Castro Sousa
Journal:  Case Rep Ophthalmol       Date:  2013-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.